Ligandability assessment of the C-terminal Rel-homology domain of NFAT1

Jark Böttcher1, Julian E Fuchs1, Moriz Mayer1

  • 1Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Archiv Der Pharmazie
|February 24, 2024
PubMed

Insights

Researchers identified small molecule fragments that bind to the nuclear factor of activated T cells 1 (NFAT1) protein domain. This finding opens new therapeutic avenues for diseases involving NFAT1, a challenging transcription factor target.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Drug Discovery

Background:

  • Transcription factors are crucial disease regulators but often considered undruggable targets.
  • Nuclear factor of activated T cells 1 (NFAT1) plays a key role in T-cell regulation and related diseases.

Purpose of the Study:

  • To assess the ligandability of the C-terminal Rel-homology domain of NFAT1.
  • To identify small molecule binders for NFAT1.

Main Methods:

  • Utilized a combination of experimental and computational approaches.
  • Employed biophysical validation methods.
  • Determined the binding mode using X-ray crystallography.

Main Results:

  • Demonstrated that small molecule fragments can bind to the NFAT1 protein domain.
  • Identified the first validated small molecule binder for NFAT1.
  • Elucidated the binding mode of the identified binder.

Conclusions:

  • The C-terminal Rel-homology domain of NFAT1 is druggable.
  • The identified binder and its eutomer/distomer pair serve as a foundation for developing potent NFAT1-targeting therapeutics.
  • This research paves the way for novel degrader or glue modalities for NFAT1-related diseases.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K